ConductScience.org, home

Paper32797366

Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place.

van Hoeve K and 1 other. Paediatr Drugs, 2020. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place. Papers, record 32797366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32797366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place.
PubMed
Journal
Paediatr Drugs
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Hoeve KKaren
2Vermeire SSéverinehttps://orcid.org/0000-0001-9942-3019

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
Immunologic FactorsMajor topic
Inflammatory Bowel DiseasesMajor topic
PurinesMajor topic
ThionucleosidesMajor topic
Child
Drug Therapy, Combination
Humans

Source PubMed

Download CSV of topics

References138

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112065760The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs.Mol Pharmacol2002https://conductscience.org/library/papers/12065760PubMed
230633088Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease.Ther Drug Monit2019https://conductscience.org/library/papers/30633088PubMed
324991785Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.Inflamm Bowel Dis2014https://conductscience.org/library/papers/24991785PubMed
425066841Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.Clin Gastroenterol Hepatol2015https://conductscience.org/library/papers/25066841PubMed
55788533Inhibition of phosphoribosyl pyrophosphate amidotransferase from Ehrlich ascites-tumour cells by thiopurine nucleotides.Biochem Pharmacol1969https://conductscience.org/library/papers/5788533PubMed
619821389Interventions for prevention of post-operative recurrence of Crohn's disease.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19821389PubMed
727271489Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.Inflamm Bowel Dis2016https://conductscience.org/library/papers/27271489PubMed
824162032Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.Gastroenterology2014https://conductscience.org/library/papers/24162032PubMed
918306311Effect of early immunomodulator use in moderate to severe pediatric Crohn disease.Inflamm Bowel Dis2008https://conductscience.org/library/papers/18306311PubMed
1029202588Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease.Expert Opin Drug Saf2018https://conductscience.org/library/papers/29202588PubMed
1116618398Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.Gastroenterology2006https://conductscience.org/library/papers/16618398PubMed
127191632Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.Am J Hum Genet1980https://conductscience.org/library/papers/7191632PubMed
1321224840Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.Am J Gastroenterol2011https://conductscience.org/library/papers/21224840PubMed
1423128233Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.Nature2012https://conductscience.org/library/papers/23128233PubMed
1522784257Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism.Aliment Pharmacol Ther2012https://conductscience.org/library/papers/22784257PubMed
1620626362Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies.Acta Paediatr2011https://conductscience.org/library/papers/20626362PubMed
1720393175Infliximab, azathioprine, or combination therapy for Crohn's disease.N Engl J Med2010https://conductscience.org/library/papers/20393175PubMed
1821910176Tolerance and efficacy of azathioprine in pediatric Crohn's disease.Inflamm Bowel Dis2011https://conductscience.org/library/papers/21910176PubMed
1910208641The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.Pharmacogenetics1999https://conductscience.org/library/papers/10208641PubMed
2012030954Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey.Aliment Pharmacol Ther2002https://conductscience.org/library/papers/12030954PubMed

See all 138 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42746383PACSIN2 regulates mercaptopurine cytotoxicity and cellular biomechanics through Rac1 modulation in intestinal epithelial cells.Front Pharmacol2026https://conductscience.org/library/papers/42746383PubMed
41292289Comparative risk of serious infection among biologic therapies for inflammatory bowel disease in pediatric patients: A target trial emulation.J Pediatr Gastroenterol Nutr2026https://conductscience.org/library/papers/41292289PubMed
41200039Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions.Matter2025https://conductscience.org/library/papers/41200039PubMed
40682730Clinical utility of thiopurine metabolite levels in monitoring patients with inflammatory bowel disease: A single-centre retrospective study.Indian J Gastroenterol2026https://conductscience.org/library/papers/40682730PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TPMT7172PubTator's text mininghttps://conductscience.org/library/genes/7172

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32797366

GET https://conductscience.org/api/papers/v1/32797366/references?page=2